• Episode 2: From Innovation to Impact: The RNA Interference Era Begins
    Jun 11 2025

    Dr. Bruce Given shares insights into Arrowhead Pharmaceuticals’ innovative approach to siRNA therapeutics and the company’s growing role in lipid management and cardiovascular care. Hosted by Dr. Peter Jones, this conversation highlights the intersection of clinical need and next-gen molecular science.

    Show more Show less
    39 mins
  • Episode 1: Inflammation and Heart Attacks: A New Frontier in Prevention with LODOCO
    Nov 26 2024

    In this episode of Industry Innovations, host Dr. Peter Jones is joined by Dr. Guy Mintz to explore an exciting advancement in cardiovascular care: LODOCO, a low-dose colchicine developed by Agepha Pharma. Backed by robust clinical trial data, LODOCO is an FDA-approved therapy targeting inflammation as a novel approach to reducing the risk of heart attacks.

    Learn how inflammation contributes to cardiovascular events and why this groundbreaking therapy is redefining prevention strategies. Dr. Mintz discusses the science, the data, and the potential impact of LODOCO on clinical practice, offering valuable insights for clinicians committed to improving patient outcomes.

    Sponsored by Agepha Pharma

    Show more Show less
    42 mins